nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—CYP2C9—Desloratadine—allergic rhinitis	0.134	0.342	CbGbCtD
Epoprostenol—CYP2C9—Montelukast—allergic rhinitis	0.0769	0.197	CbGbCtD
Epoprostenol—CYP2C9—Loratadine—allergic rhinitis	0.0769	0.197	CbGbCtD
Epoprostenol—CYP2C9—Diphenhydramine—allergic rhinitis	0.0769	0.197	CbGbCtD
Epoprostenol—PTGER1—Prostanoid ligand receptors—PTGDR2—allergic rhinitis	0.027	0.142	CbGpPWpGaD
Epoprostenol—PTGIR—Prostanoid ligand receptors—PTGDR2—allergic rhinitis	0.027	0.142	CbGpPWpGaD
Epoprostenol—CYP2C9—Dexamethasone—allergic rhinitis	0.0266	0.068	CbGbCtD
Epoprostenol—PTGIR—Eicosanoid ligand-binding receptors—PTGDR2—allergic rhinitis	0.0179	0.0943	CbGpPWpGaD
Epoprostenol—PTGER1—Eicosanoid ligand-binding receptors—PTGDR2—allergic rhinitis	0.0179	0.0943	CbGpPWpGaD
Epoprostenol—PTGER1—Eicosanoid ligand-binding receptors—CYSLTR1—allergic rhinitis	0.0141	0.074	CbGpPWpGaD
Epoprostenol—PTGIR—Eicosanoid ligand-binding receptors—CYSLTR1—allergic rhinitis	0.0141	0.074	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—ADIPOQ—allergic rhinitis	0.00216	0.0113	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.00216	0.0113	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.002	0.0105	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.00187	0.00983	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00184	0.00968	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00184	0.00968	CbGpPWpGaD
Epoprostenol—PTGIR—Thromboxane A2 receptor signaling—ICAM1—allergic rhinitis	0.00181	0.00951	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00172	0.00901	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.00167	0.00879	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00158	0.0083	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00158	0.0083	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00157	0.00826	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—SMAD3—allergic rhinitis	0.00157	0.00825	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00145	0.0076	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00145	0.0076	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00135	0.00707	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—TAC1—allergic rhinitis	0.00131	0.0069	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00131	0.00686	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.0013	0.00683	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00124	0.00651	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00124	0.00651	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—PTGDR2—allergic rhinitis	0.0012	0.00632	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.0012	0.00632	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.0012	0.00629	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.0012	0.00629	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.00117	0.00617	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.00116	0.0061	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00103	0.00539	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CCL11—allergic rhinitis	0.00099	0.0052	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000945	0.00496	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000943	0.00496	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000943	0.00496	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCL11—allergic rhinitis	0.000911	0.00479	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CCL11—allergic rhinitis	0.000911	0.00479	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000869	0.00457	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000869	0.00457	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000738	0.00388	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—TAC1—allergic rhinitis	0.000719	0.00378	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000679	0.00357	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000679	0.00357	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00067	0.00352	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—TGFB1—allergic rhinitis	0.000665	0.00349	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—TAC1—allergic rhinitis	0.000662	0.00348	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—TAC1—allergic rhinitis	0.000662	0.00348	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000617	0.00324	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000617	0.00324	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IL5—allergic rhinitis	0.000598	0.00314	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000579	0.00304	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IL5—allergic rhinitis	0.00055	0.00289	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000533	0.0028	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000533	0.0028	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000526	0.00276	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCL11—allergic rhinitis	0.000508	0.00267	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000484	0.00254	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000484	0.00254	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL11—allergic rhinitis	0.000468	0.00246	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL11—allergic rhinitis	0.000468	0.00246	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—TAC1—allergic rhinitis	0.000407	0.00214	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTGDR2—allergic rhinitis	0.000396	0.00208	CbGpPWpGaD
Epoprostenol—Acute coronary syndrome—Triamcinolone—allergic rhinitis	0.000392	0.000938	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Methylprednisolone—allergic rhinitis	0.000392	0.000936	CcSEcCtD
Epoprostenol—Haemoglobin—Prednisolone—allergic rhinitis	0.000391	0.000934	CcSEcCtD
Epoprostenol—Myocardial infarction—Triamcinolone—allergic rhinitis	0.00039	0.000933	CcSEcCtD
Epoprostenol—Myocardial infarction—Methylprednisolone—allergic rhinitis	0.000389	0.000931	CcSEcCtD
Epoprostenol—Haemorrhage—Prednisolone—allergic rhinitis	0.000389	0.000929	CcSEcCtD
Epoprostenol—Dizziness—Flunisolide—allergic rhinitis	0.000387	0.000925	CcSEcCtD
Epoprostenol—Bradycardia—Hydrocortisone—allergic rhinitis	0.000386	0.000924	CcSEcCtD
Epoprostenol—Haemoglobin—Hydrocortisone—allergic rhinitis	0.000381	0.000912	CcSEcCtD
Epoprostenol—Sweating—Methylprednisolone—allergic rhinitis	0.000381	0.00091	CcSEcCtD
Epoprostenol—Haemorrhage—Hydrocortisone—allergic rhinitis	0.00038	0.000907	CcSEcCtD
Epoprostenol—Vomiting—Cetirizine—allergic rhinitis	0.000379	0.000905	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—IL5—allergic rhinitis	0.000378	0.00199	CbGpPWpGaD
Epoprostenol—Nausea—Loratadine—allergic rhinitis	0.000376	0.000898	CcSEcCtD
Epoprostenol—Epistaxis—Triamcinolone—allergic rhinitis	0.000375	0.000897	CcSEcCtD
Epoprostenol—Rash—Cetirizine—allergic rhinitis	0.000375	0.000897	CcSEcCtD
Epoprostenol—Dermatitis—Cetirizine—allergic rhinitis	0.000375	0.000897	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—TAC1—allergic rhinitis	0.000374	0.00197	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—TAC1—allergic rhinitis	0.000374	0.00197	CbGpPWpGaD
Epoprostenol—Headache—Cetirizine—allergic rhinitis	0.000373	0.000892	CcSEcCtD
Epoprostenol—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000373	0.000891	CcSEcCtD
Epoprostenol—Vomiting—Flunisolide—allergic rhinitis	0.000372	0.00089	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—TAC1—allergic rhinitis	0.000369	0.00194	CbGpPWpGaD
Epoprostenol—Rash—Flunisolide—allergic rhinitis	0.000369	0.000882	CcSEcCtD
Epoprostenol—Dermatitis—Flunisolide—allergic rhinitis	0.000369	0.000882	CcSEcCtD
Epoprostenol—Hypersensitivity—Montelukast—allergic rhinitis	0.000368	0.000879	CcSEcCtD
Epoprostenol—Headache—Flunisolide—allergic rhinitis	0.000367	0.000877	CcSEcCtD
Epoprostenol—Weight decreased—Dexamethasone—allergic rhinitis	0.000366	0.000876	CcSEcCtD
Epoprostenol—Weight decreased—Betamethasone—allergic rhinitis	0.000366	0.000876	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—PTGDR2—allergic rhinitis	0.000364	0.00192	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000364	0.00192	CbGpPWpGaD
Epoprostenol—Bradycardia—Triamcinolone—allergic rhinitis	0.000364	0.00087	CcSEcCtD
Epoprostenol—Bradycardia—Methylprednisolone—allergic rhinitis	0.000363	0.000868	CcSEcCtD
Epoprostenol—Haemoglobin—Triamcinolone—allergic rhinitis	0.000359	0.000859	CcSEcCtD
Epoprostenol—Haemoglobin—Methylprednisolone—allergic rhinitis	0.000358	0.000857	CcSEcCtD
Epoprostenol—Rhinitis—Triamcinolone—allergic rhinitis	0.000358	0.000856	CcSEcCtD
Epoprostenol—Asthenia—Montelukast—allergic rhinitis	0.000358	0.000856	CcSEcCtD
Epoprostenol—Rhinitis—Methylprednisolone—allergic rhinitis	0.000357	0.000854	CcSEcCtD
Epoprostenol—Haemorrhage—Triamcinolone—allergic rhinitis	0.000357	0.000854	CcSEcCtD
Epoprostenol—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000357	0.000852	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Dexamethasone—allergic rhinitis	0.000356	0.000851	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Betamethasone—allergic rhinitis	0.000356	0.000851	CcSEcCtD
Epoprostenol—Pharyngitis—Triamcinolone—allergic rhinitis	0.000355	0.000848	CcSEcCtD
Epoprostenol—Myocardial infarction—Betamethasone—allergic rhinitis	0.000354	0.000846	CcSEcCtD
Epoprostenol—Myocardial infarction—Dexamethasone—allergic rhinitis	0.000354	0.000846	CcSEcCtD
Epoprostenol—Nausea—Cetirizine—allergic rhinitis	0.000354	0.000845	CcSEcCtD
Epoprostenol—Pruritus—Montelukast—allergic rhinitis	0.000353	0.000844	CcSEcCtD
Epoprostenol—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.00035	0.000838	CcSEcCtD
Epoprostenol—PTGIR—GPCR downstream signaling—IL5—allergic rhinitis	0.000348	0.00183	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL5—allergic rhinitis	0.000348	0.00183	CbGpPWpGaD
Epoprostenol—Nausea—Flunisolide—allergic rhinitis	0.000348	0.000831	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	0.000346	0.00182	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL5—allergic rhinitis	0.000343	0.0018	CbGpPWpGaD
Epoprostenol—Diarrhoea—Montelukast—allergic rhinitis	0.000342	0.000817	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—TAC1—allergic rhinitis	0.00034	0.00179	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—TAC1—allergic rhinitis	0.00034	0.00179	CbGpPWpGaD
Epoprostenol—Mental disorder—Hydrocortisone—allergic rhinitis	0.000332	0.000795	CcSEcCtD
Epoprostenol—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000331	0.000791	CcSEcCtD
Epoprostenol—Dizziness—Montelukast—allergic rhinitis	0.00033	0.000789	CcSEcCtD
Epoprostenol—Bradycardia—Betamethasone—allergic rhinitis	0.00033	0.000789	CcSEcCtD
Epoprostenol—Bradycardia—Dexamethasone—allergic rhinitis	0.00033	0.000789	CcSEcCtD
Epoprostenol—Haemoglobin—Dexamethasone—allergic rhinitis	0.000326	0.000779	CcSEcCtD
Epoprostenol—Haemoglobin—Betamethasone—allergic rhinitis	0.000326	0.000779	CcSEcCtD
Epoprostenol—Haemorrhage—Dexamethasone—allergic rhinitis	0.000324	0.000775	CcSEcCtD
Epoprostenol—Haemorrhage—Betamethasone—allergic rhinitis	0.000324	0.000775	CcSEcCtD
Epoprostenol—Angiopathy—Methylprednisolone—allergic rhinitis	0.000323	0.000773	CcSEcCtD
Epoprostenol—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000321	0.000768	CcSEcCtD
Epoprostenol—Vomiting—Montelukast—allergic rhinitis	0.000317	0.000759	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—IL5—allergic rhinitis	0.000316	0.00166	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL5—allergic rhinitis	0.000316	0.00166	CbGpPWpGaD
Epoprostenol—Rash—Montelukast—allergic rhinitis	0.000315	0.000753	CcSEcCtD
Epoprostenol—Dermatitis—Montelukast—allergic rhinitis	0.000315	0.000752	CcSEcCtD
Epoprostenol—Headache—Montelukast—allergic rhinitis	0.000313	0.000748	CcSEcCtD
Epoprostenol—Mental disorder—Methylprednisolone—allergic rhinitis	0.000312	0.000747	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000311	0.00163	CbGpPWpGaD
Epoprostenol—Syncope—Prednisolone—allergic rhinitis	0.000303	0.000725	CcSEcCtD
Epoprostenol—Back pain—Triamcinolone—allergic rhinitis	0.000301	0.000719	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—CCL11—allergic rhinitis	0.0003	0.00158	CbGpPWpGaD
Epoprostenol—Loss of consciousness—Prednisolone—allergic rhinitis	0.000297	0.000711	CcSEcCtD
Epoprostenol—Nausea—Montelukast—allergic rhinitis	0.000297	0.000709	CcSEcCtD
Epoprostenol—Syncope—Hydrocortisone—allergic rhinitis	0.000296	0.000708	CcSEcCtD
Epoprostenol—Angiopathy—Betamethasone—allergic rhinitis	0.000294	0.000703	CcSEcCtD
Epoprostenol—Angiopathy—Dexamethasone—allergic rhinitis	0.000294	0.000703	CcSEcCtD
Epoprostenol—Loss of consciousness—Hydrocortisone—allergic rhinitis	0.00029	0.000694	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000286	0.0015	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000286	0.0015	CbGpPWpGaD
Epoprostenol—Myalgia—Hydrocortisone—allergic rhinitis	0.000281	0.000672	CcSEcCtD
Epoprostenol—Anxiety—Hydrocortisone—allergic rhinitis	0.00028	0.00067	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000279	0.000668	CcSEcCtD
Epoprostenol—Syncope—Triamcinolone—allergic rhinitis	0.000279	0.000667	CcSEcCtD
Epoprostenol—Syncope—Methylprednisolone—allergic rhinitis	0.000278	0.000665	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—CCL11—allergic rhinitis	0.000276	0.00145	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL11—allergic rhinitis	0.000276	0.00145	CbGpPWpGaD
Epoprostenol—Oedema—Prednisolone—allergic rhinitis	0.000276	0.00066	CcSEcCtD
Epoprostenol—Anaphylactic shock—Prednisolone—allergic rhinitis	0.000276	0.00066	CcSEcCtD
Epoprostenol—Loss of consciousness—Triamcinolone—allergic rhinitis	0.000273	0.000654	CcSEcCtD
Epoprostenol—Loss of consciousness—Methylprednisolone—allergic rhinitis	0.000273	0.000652	CcSEcCtD
Epoprostenol—Shock—Prednisolone—allergic rhinitis	0.000272	0.000649	CcSEcCtD
Epoprostenol—Cough—Triamcinolone—allergic rhinitis	0.000271	0.000649	CcSEcCtD
Epoprostenol—Anaphylactic shock—Hydrocortisone—allergic rhinitis	0.00027	0.000645	CcSEcCtD
Epoprostenol—Oedema—Hydrocortisone—allergic rhinitis	0.00027	0.000645	CcSEcCtD
Epoprostenol—Tachycardia—Prednisolone—allergic rhinitis	0.000269	0.000644	CcSEcCtD
Epoprostenol—Infection—Hydrocortisone—allergic rhinitis	0.000268	0.00064	CcSEcCtD
Epoprostenol—Hyperhidrosis—Prednisolone—allergic rhinitis	0.000267	0.000638	CcSEcCtD
Epoprostenol—Shock—Hydrocortisone—allergic rhinitis	0.000265	0.000634	CcSEcCtD
Epoprostenol—Myalgia—Triamcinolone—allergic rhinitis	0.000265	0.000633	CcSEcCtD
Epoprostenol—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000264	0.000632	CcSEcCtD
Epoprostenol—Myalgia—Methylprednisolone—allergic rhinitis	0.000264	0.000632	CcSEcCtD
Epoprostenol—Arthralgia—Methylprednisolone—allergic rhinitis	0.000264	0.000632	CcSEcCtD
Epoprostenol—Anxiety—Methylprednisolone—allergic rhinitis	0.000263	0.000629	CcSEcCtD
Epoprostenol—Tachycardia—Hydrocortisone—allergic rhinitis	0.000263	0.000629	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000262	0.000627	CcSEcCtD
Epoprostenol—Skin disorder—Hydrocortisone—allergic rhinitis	0.000262	0.000626	CcSEcCtD
Epoprostenol—Hyperhidrosis—Hydrocortisone—allergic rhinitis	0.000261	0.000623	CcSEcCtD
Epoprostenol—Dry mouth—Triamcinolone—allergic rhinitis	0.000259	0.000619	CcSEcCtD
Epoprostenol—Anorexia—Hydrocortisone—allergic rhinitis	0.000257	0.000614	CcSEcCtD
Epoprostenol—PTGIS—Disease—SMAD3—allergic rhinitis	0.000256	0.00135	CbGpPWpGaD
Epoprostenol—Confusional state—Methylprednisolone—allergic rhinitis	0.000255	0.000611	CcSEcCtD
Epoprostenol—Oedema—Triamcinolone—allergic rhinitis	0.000254	0.000607	CcSEcCtD
Epoprostenol—Anaphylactic shock—Triamcinolone—allergic rhinitis	0.000254	0.000607	CcSEcCtD
Epoprostenol—Anaphylactic shock—Methylprednisolone—allergic rhinitis	0.000253	0.000606	CcSEcCtD
Epoprostenol—Syncope—Dexamethasone—allergic rhinitis	0.000253	0.000605	CcSEcCtD
Epoprostenol—Syncope—Betamethasone—allergic rhinitis	0.000253	0.000605	CcSEcCtD
Epoprostenol—Infection—Triamcinolone—allergic rhinitis	0.000252	0.000603	CcSEcCtD
Epoprostenol—Hypotension—Hydrocortisone—allergic rhinitis	0.000252	0.000602	CcSEcCtD
Epoprostenol—Infection—Methylprednisolone—allergic rhinitis	0.000252	0.000602	CcSEcCtD
Epoprostenol—Shock—Triamcinolone—allergic rhinitis	0.00025	0.000597	CcSEcCtD
Epoprostenol—Insomnia—Prednisolone—allergic rhinitis	0.00025	0.000597	CcSEcCtD
Epoprostenol—Shock—Methylprednisolone—allergic rhinitis	0.000249	0.000596	CcSEcCtD
Epoprostenol—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000248	0.000594	CcSEcCtD
Epoprostenol—Loss of consciousness—Dexamethasone—allergic rhinitis	0.000248	0.000593	CcSEcCtD
Epoprostenol—Loss of consciousness—Betamethasone—allergic rhinitis	0.000248	0.000593	CcSEcCtD
Epoprostenol—Paraesthesia—Prednisolone—allergic rhinitis	0.000248	0.000593	CcSEcCtD
Epoprostenol—Tachycardia—Triamcinolone—allergic rhinitis	0.000248	0.000592	CcSEcCtD
Epoprostenol—Tachycardia—Methylprednisolone—allergic rhinitis	0.000247	0.000591	CcSEcCtD
Epoprostenol—Skin disorder—Methylprednisolone—allergic rhinitis	0.000246	0.000588	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000246	0.000587	CcSEcCtD
Epoprostenol—Hyperhidrosis—Triamcinolone—allergic rhinitis	0.000245	0.000587	CcSEcCtD
Epoprostenol—Hyperhidrosis—Methylprednisolone—allergic rhinitis	0.000245	0.000585	CcSEcCtD
Epoprostenol—Insomnia—Hydrocortisone—allergic rhinitis	0.000244	0.000583	CcSEcCtD
Epoprostenol—Paraesthesia—Hydrocortisone—allergic rhinitis	0.000242	0.000579	CcSEcCtD
Epoprostenol—Myalgia—Betamethasone—allergic rhinitis	0.00024	0.000574	CcSEcCtD
Epoprostenol—Myalgia—Dexamethasone—allergic rhinitis	0.00024	0.000574	CcSEcCtD
Epoprostenol—Anxiety—Betamethasone—allergic rhinitis	0.000239	0.000572	CcSEcCtD
Epoprostenol—Anxiety—Dexamethasone—allergic rhinitis	0.000239	0.000572	CcSEcCtD
Epoprostenol—Dyspepsia—Hydrocortisone—allergic rhinitis	0.000237	0.000567	CcSEcCtD
Epoprostenol—Hypotension—Methylprednisolone—allergic rhinitis	0.000237	0.000566	CcSEcCtD
Epoprostenol—Pain—Prednisolone—allergic rhinitis	0.000236	0.000564	CcSEcCtD
Epoprostenol—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000234	0.00056	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000233	0.000556	CcSEcCtD
Epoprostenol—Fatigue—Hydrocortisone—allergic rhinitis	0.000232	0.000556	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000231	0.000553	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000231	0.000552	CcSEcCtD
Epoprostenol—Pain—Hydrocortisone—allergic rhinitis	0.000231	0.000551	CcSEcCtD
Epoprostenol—Anaphylactic shock—Dexamethasone—allergic rhinitis	0.00023	0.000551	CcSEcCtD
Epoprostenol—Oedema—Dexamethasone—allergic rhinitis	0.00023	0.000551	CcSEcCtD
Epoprostenol—Oedema—Betamethasone—allergic rhinitis	0.00023	0.000551	CcSEcCtD
Epoprostenol—Anaphylactic shock—Betamethasone—allergic rhinitis	0.00023	0.000551	CcSEcCtD
Epoprostenol—Insomnia—Triamcinolone—allergic rhinitis	0.00023	0.000549	CcSEcCtD
Epoprostenol—Insomnia—Methylprednisolone—allergic rhinitis	0.000229	0.000548	CcSEcCtD
Epoprostenol—Infection—Dexamethasone—allergic rhinitis	0.000229	0.000547	CcSEcCtD
Epoprostenol—Infection—Betamethasone—allergic rhinitis	0.000229	0.000547	CcSEcCtD
Epoprostenol—Paraesthesia—Triamcinolone—allergic rhinitis	0.000228	0.000545	CcSEcCtD
Epoprostenol—Paraesthesia—Methylprednisolone—allergic rhinitis	0.000227	0.000544	CcSEcCtD
Epoprostenol—Shock—Betamethasone—allergic rhinitis	0.000227	0.000542	CcSEcCtD
Epoprostenol—Shock—Dexamethasone—allergic rhinitis	0.000227	0.000542	CcSEcCtD
Epoprostenol—Dyspnoea—Triamcinolone—allergic rhinitis	0.000226	0.000541	CcSEcCtD
Epoprostenol—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000226	0.00054	CcSEcCtD
Epoprostenol—Nervous system disorder—Betamethasone—allergic rhinitis	0.000226	0.00054	CcSEcCtD
Epoprostenol—Thrombocytopenia—Betamethasone—allergic rhinitis	0.000226	0.000539	CcSEcCtD
Epoprostenol—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.000226	0.000539	CcSEcCtD
Epoprostenol—Tachycardia—Betamethasone—allergic rhinitis	0.000225	0.000537	CcSEcCtD
Epoprostenol—Tachycardia—Dexamethasone—allergic rhinitis	0.000225	0.000537	CcSEcCtD
Epoprostenol—Dyspepsia—Triamcinolone—allergic rhinitis	0.000223	0.000534	CcSEcCtD
Epoprostenol—Dyspepsia—Methylprednisolone—allergic rhinitis	0.000223	0.000533	CcSEcCtD
Epoprostenol—Hyperhidrosis—Dexamethasone—allergic rhinitis	0.000223	0.000532	CcSEcCtD
Epoprostenol—Hyperhidrosis—Betamethasone—allergic rhinitis	0.000223	0.000532	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.00022	0.000527	CcSEcCtD
Epoprostenol—Anorexia—Betamethasone—allergic rhinitis	0.00022	0.000525	CcSEcCtD
Epoprostenol—Anorexia—Dexamethasone—allergic rhinitis	0.00022	0.000525	CcSEcCtD
Epoprostenol—Urticaria—Prednisolone—allergic rhinitis	0.000219	0.000524	CcSEcCtD
Epoprostenol—Fatigue—Triamcinolone—allergic rhinitis	0.000219	0.000523	CcSEcCtD
Epoprostenol—Fatigue—Methylprednisolone—allergic rhinitis	0.000218	0.000522	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—TAC1—allergic rhinitis	0.000218	0.00115	CbGpPWpGaD
Epoprostenol—Pain—Triamcinolone—allergic rhinitis	0.000217	0.000519	CcSEcCtD
Epoprostenol—Hypotension—Betamethasone—allergic rhinitis	0.000215	0.000515	CcSEcCtD
Epoprostenol—Hypotension—Dexamethasone—allergic rhinitis	0.000215	0.000515	CcSEcCtD
Epoprostenol—Urticaria—Hydrocortisone—allergic rhinitis	0.000214	0.000512	CcSEcCtD
Epoprostenol—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000213	0.000509	CcSEcCtD
Epoprostenol—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000213	0.000509	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.00021	0.000502	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.00021	0.000502	CcSEcCtD
Epoprostenol—Insomnia—Betamethasone—allergic rhinitis	0.000208	0.000498	CcSEcCtD
Epoprostenol—Insomnia—Dexamethasone—allergic rhinitis	0.000208	0.000498	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.000207	0.000495	CcSEcCtD
Epoprostenol—Paraesthesia—Betamethasone—allergic rhinitis	0.000207	0.000494	CcSEcCtD
Epoprostenol—Paraesthesia—Dexamethasone—allergic rhinitis	0.000207	0.000494	CcSEcCtD
Epoprostenol—Hypersensitivity—Prednisolone—allergic rhinitis	0.000203	0.000486	CcSEcCtD
Epoprostenol—Dyspepsia—Dexamethasone—allergic rhinitis	0.000203	0.000485	CcSEcCtD
Epoprostenol—Dyspepsia—Betamethasone—allergic rhinitis	0.000203	0.000485	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—IL5—allergic rhinitis	0.000203	0.00107	CbGpPWpGaD
Epoprostenol—Urticaria—Triamcinolone—allergic rhinitis	0.000202	0.000482	CcSEcCtD
Epoprostenol—Urticaria—Methylprednisolone—allergic rhinitis	0.000201	0.000481	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—TAC1—allergic rhinitis	0.000201	0.00105	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TAC1—allergic rhinitis	0.000201	0.00105	CbGpPWpGaD
Epoprostenol—Body temperature increased—Triamcinolone—allergic rhinitis	0.000201	0.00048	CcSEcCtD
Epoprostenol—Abdominal pain—Methylprednisolone—allergic rhinitis	0.0002	0.000479	CcSEcCtD
Epoprostenol—Decreased appetite—Dexamethasone—allergic rhinitis	0.0002	0.000479	CcSEcCtD
Epoprostenol—Decreased appetite—Betamethasone—allergic rhinitis	0.0002	0.000479	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000199	0.000475	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000199	0.000475	CcSEcCtD
Epoprostenol—Hypersensitivity—Hydrocortisone—allergic rhinitis	0.000199	0.000475	CcSEcCtD
Epoprostenol—Fatigue—Dexamethasone—allergic rhinitis	0.000199	0.000475	CcSEcCtD
Epoprostenol—Fatigue—Betamethasone—allergic rhinitis	0.000199	0.000475	CcSEcCtD
Epoprostenol—Pain—Betamethasone—allergic rhinitis	0.000197	0.000471	CcSEcCtD
Epoprostenol—Pain—Dexamethasone—allergic rhinitis	0.000197	0.000471	CcSEcCtD
Epoprostenol—Asthenia—Hydrocortisone—allergic rhinitis	0.000193	0.000462	CcSEcCtD
Epoprostenol—Pruritus—Hydrocortisone—allergic rhinitis	0.000191	0.000456	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.000188	0.00045	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.000188	0.00045	CcSEcCtD
Epoprostenol—Hypersensitivity—Triamcinolone—allergic rhinitis	0.000187	0.000447	CcSEcCtD
Epoprostenol—Hypersensitivity—Methylprednisolone—allergic rhinitis	0.000187	0.000446	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—IL5—allergic rhinitis	0.000187	0.00098	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL5—allergic rhinitis	0.000187	0.00098	CbGpPWpGaD
Epoprostenol—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000184	0.000441	CcSEcCtD
Epoprostenol—Urticaria—Betamethasone—allergic rhinitis	0.000183	0.000437	CcSEcCtD
Epoprostenol—Urticaria—Dexamethasone—allergic rhinitis	0.000183	0.000437	CcSEcCtD
Epoprostenol—Dizziness—Prednisolone—allergic rhinitis	0.000183	0.000436	CcSEcCtD
Epoprostenol—Asthenia—Triamcinolone—allergic rhinitis	0.000182	0.000435	CcSEcCtD
Epoprostenol—Abdominal pain—Dexamethasone—allergic rhinitis	0.000182	0.000435	CcSEcCtD
Epoprostenol—Body temperature increased—Betamethasone—allergic rhinitis	0.000182	0.000435	CcSEcCtD
Epoprostenol—Abdominal pain—Betamethasone—allergic rhinitis	0.000182	0.000435	CcSEcCtD
Epoprostenol—Body temperature increased—Dexamethasone—allergic rhinitis	0.000182	0.000435	CcSEcCtD
Epoprostenol—Asthenia—Methylprednisolone—allergic rhinitis	0.000182	0.000434	CcSEcCtD
Epoprostenol—Pruritus—Triamcinolone—allergic rhinitis	0.00018	0.000429	CcSEcCtD
Epoprostenol—Pruritus—Methylprednisolone—allergic rhinitis	0.000179	0.000428	CcSEcCtD
Epoprostenol—Dizziness—Hydrocortisone—allergic rhinitis	0.000178	0.000426	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—TGFB1—allergic rhinitis	0.000178	0.000936	CbGpPWpGaD
Epoprostenol—Rash—Prednisolone—allergic rhinitis	0.000174	0.000416	CcSEcCtD
Epoprostenol—Dermatitis—Prednisolone—allergic rhinitis	0.000174	0.000416	CcSEcCtD
Epoprostenol—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000173	0.000414	CcSEcCtD
Epoprostenol—Headache—Prednisolone—allergic rhinitis	0.000173	0.000413	CcSEcCtD
Epoprostenol—Vomiting—Hydrocortisone—allergic rhinitis	0.000171	0.00041	CcSEcCtD
Epoprostenol—Rash—Hydrocortisone—allergic rhinitis	0.00017	0.000406	CcSEcCtD
Epoprostenol—Dermatitis—Hydrocortisone—allergic rhinitis	0.00017	0.000406	CcSEcCtD
Epoprostenol—Headache—Hydrocortisone—allergic rhinitis	0.000169	0.000404	CcSEcCtD
Epoprostenol—Dizziness—Triamcinolone—allergic rhinitis	0.000168	0.000401	CcSEcCtD
Epoprostenol—Dizziness—Methylprednisolone—allergic rhinitis	0.000168	0.0004	CcSEcCtD
Epoprostenol—Asthenia—Betamethasone—allergic rhinitis	0.000165	0.000395	CcSEcCtD
Epoprostenol—Asthenia—Dexamethasone—allergic rhinitis	0.000165	0.000395	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—TGFB1—allergic rhinitis	0.000164	0.000862	CbGpPWpGaD
Epoprostenol—Nausea—Prednisolone—allergic rhinitis	0.000164	0.000392	CcSEcCtD
Epoprostenol—Pruritus—Betamethasone—allergic rhinitis	0.000163	0.00039	CcSEcCtD
Epoprostenol—Pruritus—Dexamethasone—allergic rhinitis	0.000163	0.00039	CcSEcCtD
Epoprostenol—Vomiting—Triamcinolone—allergic rhinitis	0.000161	0.000386	CcSEcCtD
Epoprostenol—Vomiting—Methylprednisolone—allergic rhinitis	0.000161	0.000385	CcSEcCtD
Epoprostenol—Nausea—Hydrocortisone—allergic rhinitis	0.00016	0.000383	CcSEcCtD
Epoprostenol—Rash—Triamcinolone—allergic rhinitis	0.00016	0.000383	CcSEcCtD
Epoprostenol—Dermatitis—Triamcinolone—allergic rhinitis	0.00016	0.000382	CcSEcCtD
Epoprostenol—Rash—Methylprednisolone—allergic rhinitis	0.00016	0.000382	CcSEcCtD
Epoprostenol—Dermatitis—Methylprednisolone—allergic rhinitis	0.00016	0.000381	CcSEcCtD
Epoprostenol—Headache—Triamcinolone—allergic rhinitis	0.000159	0.00038	CcSEcCtD
Epoprostenol—Headache—Methylprednisolone—allergic rhinitis	0.000159	0.000379	CcSEcCtD
Epoprostenol—Diarrhoea—Betamethasone—allergic rhinitis	0.000158	0.000377	CcSEcCtD
Epoprostenol—Diarrhoea—Dexamethasone—allergic rhinitis	0.000158	0.000377	CcSEcCtD
Epoprostenol—Dizziness—Dexamethasone—allergic rhinitis	0.000152	0.000364	CcSEcCtD
Epoprostenol—Dizziness—Betamethasone—allergic rhinitis	0.000152	0.000364	CcSEcCtD
Epoprostenol—PTGIS—Disease—CD4—allergic rhinitis	0.000151	0.000794	CbGpPWpGaD
Epoprostenol—Nausea—Triamcinolone—allergic rhinitis	0.000151	0.00036	CcSEcCtD
Epoprostenol—Nausea—Methylprednisolone—allergic rhinitis	0.00015	0.00036	CcSEcCtD
Epoprostenol—Vomiting—Betamethasone—allergic rhinitis	0.000146	0.00035	CcSEcCtD
Epoprostenol—Vomiting—Dexamethasone—allergic rhinitis	0.000146	0.00035	CcSEcCtD
Epoprostenol—Rash—Dexamethasone—allergic rhinitis	0.000145	0.000347	CcSEcCtD
Epoprostenol—Rash—Betamethasone—allergic rhinitis	0.000145	0.000347	CcSEcCtD
Epoprostenol—Dermatitis—Dexamethasone—allergic rhinitis	0.000145	0.000347	CcSEcCtD
Epoprostenol—Dermatitis—Betamethasone—allergic rhinitis	0.000145	0.000347	CcSEcCtD
Epoprostenol—Headache—Betamethasone—allergic rhinitis	0.000144	0.000345	CcSEcCtD
Epoprostenol—Headache—Dexamethasone—allergic rhinitis	0.000144	0.000345	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—SMAD3—allergic rhinitis	0.000143	0.00075	CbGpPWpGaD
Epoprostenol—Nausea—Dexamethasone—allergic rhinitis	0.000137	0.000327	CcSEcCtD
Epoprostenol—Nausea—Betamethasone—allergic rhinitis	0.000137	0.000327	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—SMAD3—allergic rhinitis	0.000131	0.00069	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SMAD3—allergic rhinitis	0.000131	0.00069	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TGFB1—allergic rhinitis	0.000108	0.00057	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NFKB1—allergic rhinitis	7.25e-05	0.000381	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NFKB1—allergic rhinitis	6.68e-05	0.000351	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NFKB1—allergic rhinitis	6.68e-05	0.000351	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TGFB1—allergic rhinitis	6.04e-05	0.000317	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TGFB1—allergic rhinitis	5.56e-05	0.000292	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TGFB1—allergic rhinitis	5.56e-05	0.000292	CbGpPWpGaD
